Arimidex is now approved to treat EARLY breast cancer

Arimidex is now approved to treat EARLY breast cancer.

Tamoxifen is currently the standard for women with estrogen receptor-positive breast cancer.

Both tamoxifen and Arimidex reduce the effect of estrogen on tumor cells...but they work in different ways. Tamoxifen blocks estrogen receptors...Arimidex suppresses estrogen synthesis.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote